Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus

Science Translational Medicine

Volumn 3, Issue 73, 2011, Pages

  Garcia Romo, Gina S ^a   Caielli, Simone ^a   Vega, Barbara ^a   Connolly, John ^a   Allantaz, Florence ^a   Xu, Zhaohui ^a   Punaro, Marilynn ^b,c   Baisch, Jeanine ^a   Guiducci, Cristiana ^d   Coffman, Robert L ^d   Barrat, Franck J ^d   Banchereau, Jacques ^a,e   Pascual, Virginia ^a,b  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d Dynavax Technologies Corporation   (United States)

^e HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CELL DNA; CELL PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERFERON; RIBONUCLEOPROTEIN ANTIBODY; TOLL LIKE RECEPTOR 9; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; FC RECEPTOR; FC RECEPTOR IIA; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RIBONUCLEOPROTEIN; TLR7 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 7;

ADOLESCENT; ARTICLE; CELL ACTIVATION; CELL DEATH; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IN VIVO STUDY; MAMMAL CELL; NEUTROPHIL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; APOPTOSIS; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CHILD; DENDRITIC CELL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; PATHOLOGY;

ADOLESCENT; ANTIBODIES, ANTINUCLEAR; APOPTOSIS; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; DENDRITIC CELLS; GENE EXPRESSION PROFILING; HUMANS; INTERFERON TYPE I; LUPUS ERYTHEMATOSUS, SYSTEMIC; NADP; NEUTROPHILS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, IGG; RIBONUCLEOPROTEINS; TOLL-LIKE RECEPTOR 7;

EID: 79952476762     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3001201     Document Type: Article

References (46)

1. R. G. Lahita, Systemic Lupus Erythematosus (Academic Press, San Diego, ed. 3, 1999).
2. E. K. Wakeland, K. Liu, R. R. Graham, T. W. Behrens, Delineating the genetic basis of systemic lupus erythematosus. Immunity 15, 397-408 (2001).
3. S. J. Rozzo, J. D. Allard, D. Choubey, T. J. Vyse, S. Izui, G. Peltz, B. L. Kotzin, Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15, 435-443 (2001).
4. V. Pascual, J. Banchereau, A. K. Palucka, The central role of dendritic cells and interferon-α in SLE. Curr. Opin. Rheumatol. 15, 548-556 (2003).
5. P. Blanco, A. K. Palucka, M. Gill, V. Pascual, J. Banchereau, Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294, 1540-1543 (2001).
6. L. Farkas, K. Beiske, F. Lund-Johansen, P. Brandtzaeg, F. L. Jahnsen, Plasmacytoid dendritic cells (natural interferon-α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159, 237-243 (2001).
7. S. Blomberg, M. L. Eloranta, B. Cederblad, K. Nordlin, G. V. Alm, L. Rönnblom, Presence of cutaneous interferon-α producing cells in patients with systemic lupus erythematosus. Lupus 10, 484-490 (2001).
8. M. Tucci, C. Quatraro, L. Lombardi, C. Pellegrino, F. Dammacco, F. Silvestris, Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: Role of interleukin-18. Arthritis Rheum. 58, 251-262 (2008).
9. L. Bennett, A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, V. Pascual, Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197, 711-723 (2003).
10. E. C. Baechler, F. M. Batliwalla, G. Karypis, P.M. Gaffney,W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, P. K. Gregersen, T. W. Behrens, Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U.S.A. 100, 2610-2615 (2003).
11. L. C. Lit, C. K. Wong, L. S. Tam, E. K. Li, C. W. Lam, Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 65, 209-215 (2006).
12. A. Doreau, A. Belot, J. Bastid, B. Riche, M. C. Trescol-Biemont, B. Ranchin, N. Fabien, P. Cochat, C. Pouteil-Noble, P. Trolliet, I. Durieu, J. Tebib, B. Kassai, S. Ansieau, A. Puisieux, J. F. Eliaou, N. Bonnefoy- Bérard, Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat. Immunol. 10, 778-785 (2009).
13. A. Midgley, Z. McLaren, R. J. Moots, S. W. Edwards, M. W. Beresford, The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum. 60, 2390-2401 (2009).
14. V. Brinkmann, U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, D. S. Weiss, Y. Weinrauch, A. Zychlinsky, Neutrophil extracellular traps kill bacteria. Science 303, 1532-1535 (2004).
15. S. Martinelli, M. Urosevic, A. Daryadel, P. A. Oberholzer, C. Baumann, M. F. Fey, R. Dummer, H. U. Simon, S. Yousefi, Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation. J. Biol. Chem. 279, 44123-44132 (2004).
16. T. A. Fuchs, U. Abed, C. Goosmann, R. Hurwitz, I. Schulze, V. Wahn, Y.Weinrauch, V. Brinkmann, A. Zychlinsky, Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176, 231-241 (2007).
17. O. Hotta, T. Oda, Y. Taguma, H. Kitamura, S. Chiba, S. Miyazawa, H. Nagura, Role of neutrophil elastase in the development of renal necrotizing vasculitis. Clin. Nephrol. 45, 211-216 (1996).
18. F. J. Qasim, P. W. Mathieson, F. Sendo, S. Thiru, D. B. Oliveira, Role of neutrophils in the pathogenesis of experimental vasculitis. Am. J. Pathol. 149, 81-89 (1996).
19. H. A. Austin III, L. R. Muenz, K. M. Joyce, T. T. Antonovych, J. E. Balow, Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome. Kidney Int. 25, 689-695 (1984).
20. H. I. Brunner, M. Mueller, C. Rutherford, M. H. Passo, D. Witte, A. Grom, J. Mishra, P. Devarajan, Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 54, 2577-2584 (2006).
21. F. Hayashi, T. K. Means, A. D. Luster, Toll-like receptors stimulate human neutrophil function. Blood 102, 2660-2669 (2003).
22. U. Båve, G. V. Alm, L. Rönnblom, The combination of apoptotic U937 cells and lupus IgG is a potent IFN-α inducer. J. Immunol. 165, 3519-3526 (2000).
23. E. A. Leadbetter, I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, A. Marshak-Rothstein, Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603-607 (2002).
24. R. Lande, J. Gregorio, V. Facchinetti, B. Chatterjee, Y. H. Wang, B. Homey, W. Cao, Y. H. Wang, B. Su, F. O. Nestle, T. Zal, I. Mellman, J. M. Schröder, Y. J. Liu, M. Gilliet, Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564-569 (2007).
25. D. Ganguly, G. Chamilos, R. Lande, J. Gregorio, S. Meller, V. Facchinetti, B. Homey, F. J. Barrat, T. Zal, M. Gilliet, Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 206, 1983-1994 (2009).
26. H. Yanai, T. Ban, Z. Wang, M. K. Choi, T. Kawamura, H. Negishi, M. Nakasato, Y. Lu, S. Hangai, R. Koshiba, D. Savitsky, L. Ronfani, S. Akira, M. E. Bianchi, K. Honda, T. Tamura, T. Kodama, T. Taniguchi, HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462, 99-103 (2009).
27. R. M. Steinman, S. Turley, I. Mellman, K. Inaba, The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191, 411-416 (2000).
28. C. Nathan, Neutrophils and immunity: Challenges and opportunities. Nat. Rev. Immunol. 6, 173-182 (2006).
29. M. M. Hargraves, H. Richmond, R. Morton, Presentation of two bone marrow elements; the tart cell and the L.E. cell. Mayo Clin. Proc. 23, 25-28 (1948).
30. J. R. Haserick, D. W. Bortz, A new diagnostic test for acute disseminated lupus erythematosus. Cleve. Clin. Q. 16, 158-161 (1949).
31. J. R. Haserick, D. W. Bortz, Normal bone marrow inclusion phenomena induced by lupus erythematosus plasma. J. Invest. Dermatol. 13, 47-49 (1949).
32. C. W. Baugh, P. M. Kirol, M. V. Sachs, Demonstration and titration of anti-nuclear antibodies in systemic lupus erythematosus. Can. Med. Assoc. J. 83, 571-580 (1960).
33. M. K. Crow, J. Wohlgemuth, Microarray analysis of gene expression in lupus. Arthritis Res. Ther. 5, 279-287 (2003).
34. T. Lövgren, M. L. Eloranta, U. Båve, G. V. Alm, L. Rönnblom, Induction of interferon-α production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 50, 1861-1872 (2004).
35. M. L. Eloranta, T. Lövgren, D. Finke, L. Mathsson, J. Rönnelid, B. Kastner, G. V. Alm, L. Rönnblom, Regulation of the interferon-α production induced by RNA-containing immune complexes in plasmacytoid dendritic cells. Arthritis Rheum. 60, 2418-2427 (2009).
36. F. J. Barrat, T. Meeker, J. Gregorio, J. H. Chan, S. Uematsu, S. Akira, B. Chang, O. Duramad, R. L. Coffman, Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors andmay promote systemic lupus erythematosus. J. Exp. Med. 202, 1131-1139 (2005).
37. U. Båve, M. Magnusson, M. L. Eloranta, A. Perers, G. V. Alm, L. Rönnblom, FcgRIIa is expressed on natural IFN-α-producing cells (plasmacytoid dendritic cells) and is required for the IFN-α production induced by apoptotic cells combined with lupus IgG. J. Immunol. 171, 3296-3302 (2003).
38. J. Tian, A. M. Avalos, S. Y. Mao, B. Chen, K. Senthil, H. Wu, P. Parroche, S. Drabic, D. Golenbock, C. Sirois, J. Hua, L. L. An, L. Audoly, G. La Rosa, A. Bierhaus, P. Naworth, A. Marshak-Rothstein, M. K. Crow, K. A. Fitzgerald, E. Latz, P. A. Kiener, A. J. Coyle, Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8, 487-496 (2007).
39. T. Satoh, H. Kato, Y. Kumagai, M. Yoneyama, S. Sato, K. Matsushita, T. Tsujimura, T. Fujita, S. Akira, O. Takeuchi, LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc. Natl. Acad. Sci. U.S.A. 107, 1512-1517 (2010).
40. K. Kessenbrock, M. Krumbholz, U. Schönermarck, W. Back, W. L. Gross, Z. Werb, H. J. Gröne, V. Brinkmann, D. E. Jenne, Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15, 623-625 (2009).
41. K. L. Moser, J. A. Kelly, C. J. Lessard, J. B. Harley, Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun. 10, 373-379 (2009).
42. A. Hakkim, B. G. Fürnrohr, K. Amann, B. Laube, U. A. Abed, V. Brinkmann, M. Herrmann, R. E. Voll, A. Zychlinsky, Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl. Acad. Sci. U.S.A. 107, 9813-9818 (2010).
43. D. Chaussabel, C. Quinn, J. Shen, P. Patel, C. Glaser, N. Baldwin, D. Stichweh, D. Blankenship, L. Li, I. Munagala, L. Bennett, F. Allantaz, A. Mejias, M. Ardura, E. Kaizer, L. Monnet, W. Allman, H. Randall, D. Johnson, A. Lanier, M. Punaro, K. M. Wittkowski, P. White, J. Fay, G. Klintmalm, O. Ramilo, A. K. Palucka, J. Banchereau, V. Pascual, A modular analysis framework for blood genomics studies: Application to systemic lupus erythematosus. Immunity 29, 150-164 (2008).
44. F. Goldblatt, S. Chambers, A. Rahman, D. A. Isenberg, Serious infections in British patients with systemic lupus erythematosus: Hospitalisations and mortality. Lupus 18, 682-689 (2009).
45. M. C. Hochberg, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40, 1725 (1997).
46. W. Bencivelli, C. Vitali, D. A. Isenberg, J. S. Smolen,M. L. Snaith,M. Sciuto, S. Bombardieri, Disease activity in systemic lupus erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE. Clin. Exp. Rheumatol. 10, 549-554 (1992).